The outlook of companies tied to flagship drugs like Viagra presents a complex investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key territories has introduced substantial risk . Investors are now grappling with the impact of rival medications , redu